AmTrust Financial Servs Stock (OTC: AFSIB)

Latest news for AmTrust Financial Servs (OTC:AFSIB) Stock

AmTrust Financial Services Inc is a multinational company that underwrites and provides property and casualty insurance products. The company specializes in coverage for small to mid-sized businesses, with a philosophical focus on niche diversity and low-hazard risk. AmTrust's business model strives to achieve its profit goals through geographic and product diversification. The company reports three business segments: Small Commercial Business, Specialty Risk and Extended Warranty, and Specialty Program. The vast majority of revenues is derived from its Small Commercial Business risk.

AMTRUST FINCL D/S PFD B by AmTrust Financial Services, Inc.

AmTrust Financial Services Inc

Traders eyeing U.S. retail giants like Amazon.com Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AMZN#NASDAQ">AMZN</a>), Walmart Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/WMT#NYSE">WMT</a>) and Best Buy ahead of Black Friday and Cyber Monday may be in for an unpleasant surprise <a href="https://www.benzinga.com/news/large-cap/24/11/42094649/nvidia-stock-historically-drops-in-december-after-q3-earnings">as December kicks in.</a>
Despite the holiday shopping frenzy, historical data spanning decades suggests December is not the ideal month to invest in these retail behemoths.
<h2 class="wp-block-heading">December Is (Not) The Most Wonderful Time Of The Year For Walmart</h2>
Over the last 20 years, December has been Walmart&#8217;s weakest month of the year. 
Shares of Walmart fell by an average of 1.1% during the month, marking their worst average monthly performance.
Adding to the gloom, Walmart shares have only closed December in positive territory 40% of the time—just 8 times in 20 years. This is the lowest winning ratio for any month in the calendar year.
The retailer&#8217;s worst December performance in recent history occurred in 2022, when Walmart shares tumbled 7% during the month.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="458" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154522/image-257-1024x458.png" alt="" class="wp-image-661722" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154522/image-257-1024x458.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154522/image-257-300x134.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154522/image-257-768x343.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154522/image-257-1536x686.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154522/image-257.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
When extending the timeframe to 30 years, the data remains consistent: December is still Walmart&#8217;s worst-performing month, with shares dropping 0.9% on average and maintaining a winning ratio of just 40%.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="458" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154607/image-258-1024x458.png" alt="" class="wp-image-661724" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154607/image-258-1024x458.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154607/image-258-300x134.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154607/image-258-768x343.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154607/image-258-1536x686.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22154607/image-258.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
Read also: <a href="https://www.benzinga.com/24/11/42124676/november-small-cap-surge-could-carry-into-decembers-santa-rally-historical-trends-suggest">November Small-Cap Surge Could Carry Into December&#8217;s Santa Rally, Historical Trends Suggest</a>
<h2 class="wp-block-heading">Amazon Also Sees Red In December</h2>
Amazon.com Inc. also tends to falter during the holiday season. While the e-commerce giant doesn't post losses as steep as Walmart's, December ranks as Amazon's second-worst month for stock performance, trailing only February.
Over the last 20 years, Amazon shares have fallen an average of 0.27% in December, with a winning ratio of just 45%.
The worst December on record came recently in 2022, when Amazon's stock plummeted by 13%, reflecting broader market turbulence. 
However, December hasn't always been grim—Amazon saw some standout gains in the past, including a 20.1% rally in 2008 and an 11.6% jump in 2004.
<figure class="wp-block-image size-large"><img loading="lazy" decoding="async" width="1024" height="466" src="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22155251/image-260-1024x466.png" alt="" class="wp-image-661728" srcset="https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22155251/image-260-1024x466.png 1024w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22155251/image-260-300x137.png 300w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22155251/image-260-768x350.png 768w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22155251/image-260-1536x699.png 1536w,https://editorial-assets.benzinga.com/wp-content/uploads/2024/11/22155251/image-260.png 1920w" sizes="(max-width: 1024px) 100vw, 1024px" /></figure>
<h3 class="wp-block-heading">Why Do Amazon And Walmart Struggle During the Holidays?</h3>
At first glance, the holiday season—a time of frenzied shopping activity—might seem like a boon for retail stocks. But Wall Street investors often shy away from buying retail giants like Amazon and Walmart during this period, and the reasons boil down to profit margins.
Black Friday and Cyber Monday deals may boost revenue, but they also weigh on profit margins. The steep discounts needed to attract consumers during the holidays often lead to margin compression, a red flag for investors prioritizing profitability.
The holiday period is typically when expectations for retail performance are already sky-high. If results don't meet or exceed those lofty benchmarks, stocks often sell-off.
Read Next:
<ul>
<li><a href="https://www.benzinga.com/news/global/24/11/42118286/7-us-natural-gas-stocks-to-watch-as-henry-hub-prices-surge-50-in-november">7 US Natural Gas Stocks To Watch As Henry Hub Prices Surge 50% In November</a></li>
</ul>
Photo: Shutterstock

Equities

Large Cap

AMZN

Why Walmart, Amazon Stock Could Stumble This Holiday Season

The Board of Directors of RGC Resources, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/RGCO#NASDAQ">RGCO</a>), at its meeting on November 22, 2024, declared a quarterly dividend of $0.2075 per share on the Company's common stock. The indicated annual dividend is $0.83 per share, a $0.03, or 3.8%, per share increase over the prior annual level. The Company has now increased the annual dividend 21 consecutive years. Paul Nester, CEO of RGC Resources, Inc., stated, "The Roanoke Gas utility continues to deliver solid operational and financial performance. Further, we are pleased that the MVP was completed in 2024 and now delivering affordable, reliable natural gas to Southwest Virginia. This dividend increase, our 21st annual increase, reflects our commitment to deliver long-term shareholder value." The dividend will be paid on February 1, 2025 to shareholders of record on January 17, 2025. This is the Company's 323rd consecutive quarterly cash dividend.
RGC Resources, Inc. provides energy and related products and services to customers in Virginia through its operating subsidiaries including Roanoke Gas Company and RGC Midstream, L.L.C.

News

Dividends

RGCO

RGC Resources Increases Quarterly Dividend From $0.20 To $0.2075 Per Share

RGC Resources Announced It Has Raised Its Annual Dividend From $0.80 to $0.83

Jones Trading analyst Jason Weaver maintains Annaly Capital Management (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/NLY#NYSE">NLY</a>) with a Buy and maintains $21 price target.

Price Target

Analyst Ratings

Jones Trading Maintains Buy on Annaly Capital Management, Maintains $21 Price Target

CUTR

Cutera On Nov 19, Got Notice From Nasdaq On Failure To Satisfy A Continued Listing Rule Or Standard

Merck (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MRK#NYSE">MRK</a>), known as MSD outside the United States and Canada, has been notified that TRC Capital Investment Corporation (TRC Capital) has commenced an unsolicited "mini-tender" offer, dated November 12, 2024, to purchase up to 1,000,000 shares of Merck common stock at $96.38 per share. The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024 ($100.73), the last trading day before the date of the offer, and approximately 3.48% below the closing price of the Merck common stock on November 21, 2024 ($99.86), the day prior to this release.
Merck does not endorse TRC Capital's offer and recommends that Merck shareholders reject the offer and not tender their shares in response to TRC Capital's unsolicited mini-tender offer. This mini-tender offer is at a price below the closing price for Merck's shares (as of the day prior to this release) and is subject to numerous conditions, including TRC Capital's ability to obtain financing. Merck is not associated in any way with TRC Capital, its mini-tender offer or the offer documentation.

Management

Merck Recommends Rejection Of TRC Capital's "Mini-Tender" Offer To Purchase Up To 1M Shares Of Common Stock At $96.38 Per Share

The Las Vegas Grand Prix kicked off with an unexpected twist this week at <a href="https://www.benzinga.com/markets/cannabis/24/04/38181178/exclusive-fifteen-new-f1-hybrid-cannabis-strains-to-hit-shelves-in-us-for-420-under-new-partners">Formula 1</a>. During the second free practice session, it wasn't the usual track talk about lap times or track conditions being discussed by the drivers. Instead, they were commenting on the pervasive cannabis aroma filling the air around the circuit.
See Also: <a href="https://www.benzinga.com/markets/cannabis/24/10/41403643/cannabis-can-be-a-great-tool-in-dealing-with-adversity-says-former-nfl-star-ricky-williams">Cannabis Can Be A &#8216;Great Tool In Dealing With Adversity,&#8217; Says Former NFL Star Ricky Williams</a>
The first to bring it up was young Argentine driver Colapinto. After his media interview following practice, he made a candid observation that quickly went viral.
"Yes, there was a smell of weed. If they do a doping test on the drivers now, I think everyone would test positive, I swear," Colapinto joked. 
"When we all test positive, it'll be a mess," the 21-year-old William&#8217;s driver said in a playful tone.
<figure class="wp-block-embed is-type-video is-provider-youtube wp-block-embed-youtube wp-embed-aspect-16-9 wp-has-aspect-ratio"> 
<div class="wp-block-embed__wrapper">
<iframe loading="lazy" title="Insólito comentario de Colapinto: &quot;Sí, había olor a porro&quot; &#x7C; Cadena 3 Argentina" width="500" height="281" src="https://www.youtube.com/embed/Gta2uN9RYpg?feature=oembed" frameborder="0" allow="accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share" referrerpolicy="strict-origin-when-cross-origin" allowfullscreen></iframe>
</div>
</figure>
Colapinto wasn't alone in noticing the cannabis scent. Red Bull's Sergio &#8220;Checo&#8221; Pérez also weighed in, concerned about the track conditions: &#8220;Practice 1 was a total disaster, the track was very dirty.&#8221;
<a href="https://www.infobae.com/deportes/2024/11/22/habia-olor-a-porro-la-desopilante-revelacion-de-franco-colapinto-tras-sus-primeras-vueltas-en-el-gran-premio-de-las-vegas/">According </a>to Infobae, he quickly added: "What's really noticeable around the whole circuit is the smell of marijuana all night long. I'm a little tired of it, the amount of odor is unbelievable. It's something that all the drivers will surely talk about."
<h3 class="wp-block-heading">Cannabis In Las Vegas: What You Need to Know</h3>
Since recreational cannabis became legal in Nevada in 2017, adults 21 and over can legally possess up to 2.5 ounces of cannabis flower or 0.25 ounces of THC concentrate, including edibles. 
However, while cannabis use is widespread in the city, public consumption remains off-limits. Smoking or using cannabis in public places is prohibited, with consumption confined to private residences or licensed lounges.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/cannabis/24/08/40558915/will-cannabis-be-a-game-changer-for-athletes-nfls-1m-study-suggests-it-could">Will Cannabis Be A Game-Changer For Athletes? NFL&#8217;s $1M Study Suggests It Could</a></li>
</ul>
Image created using photos from Shutterstock and Unsplash.

Cannabis

Sports

Markets

General

Formula 1 Drivers React To Cannabis Smell At Las Vegas Grand Prix: 'Everyone Would Test Positive'

Macquarie analyst Tim Nollen maintains Warner Music Gr (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/WMG#NASDAQ">WMG</a>) with a Neutral and maintains $30 price target.

Macquarie Maintains Neutral on Warner Music Gr, Maintains $30 Price Target

The Board of Directors of Cornerstone Strategic Value Fund, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CLM#NYSE">CLM</a>) (CUSIP: 21924B302) ("CLM") has approved a change to the name of CLM. This change will become effective December 6, 2024.&nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp;
CLM's name will change from "Cornerstone Strategic Value Fund, Inc." to "Cornerstone Strategic Investment Fund, Inc." There will be no changes to CLM's investment objective, investment policies or restrictions in connection with this name change. In addition, CLM's ticker symbol and CUSIP number will not change.

Cornerstone Strategic Value Fund, Inc. Announces Name Change To The Name Of CLM

The Company is committed to completing a deliberate, thorough investigation while diligently working to fulfill all reporting obligations and currently expects to file the Form 10-Q within the six-month period granted by the NYSE Notice; however, there can be no assurance that the Form 10-Q will be filed within such period.

Universal Corporation Receives NYSE Notice Regarding Filing Of Form 10-Q

Community Health Systems To Sell Shorepoint Health System In Florida To AdventHealth For $265M; Deal Includes Port Charlotte And Punta Gorda Facilities, Closing Expected Q1 2025

Legal and political dynamics intensified as President-elect Donald Trump secured a delay in his New York sentencing on felony counts of falsifying business records, while his legal team pushes for dismissal under <a href="https://www.benzinga.com/topic/donald-trump">presidential immunity protections. </a>
The case, stemming from payments tied to adult film actress Stormy Daniels during the 2016 election, now faces fresh questions amid Trump's imminent return to the presidency.
What Happened: State Judge Juan Merchan granted Trump's request to postpone sentencing to consider arguments about immunity, NBC News <a href="https://www.nbcnews.com/politics/donald-trump/judge-trump-hush-money-case-postpones-sentencing-consider-whether-case-rcna180861">reports</a>. Trump's attorneys assert that the recent Supreme Court decision on presidential protections applies to his conviction, seeking to have the case dismissed entirely. 
Proceedings have been rescheduled, with defense filings due by Dec. 2 and responses from prosecutors by Dec. 9.
Prosecutors acknowledged Trump's status as president-elect presents unprecedented legal questions. According to NBC News, they suggested sentencing could be deferred until the end of his term, citing the need to balance constitutional interests.
Also Read: <a href="https://www.benzinga.com/news/global/24/11/42126727/nate-silver-says-biden-should-resign-have-harris-take-over-presidency-its-a-very-difficult-job">Nate Silver Says Biden Should Resign, Have Harris Take Over Presidency: &#8216;It&#8217;s A Very Difficult Job&#8217;</a>
Why It Matters: The delay underscores the broader implications of presidential immunity, a contentious issue reshaped by recent Supreme Court rulings. As Trump prepares to take office in January, his legal battles highlight the tension between political power and judicial accountability.
Separately, Trump announced the nomination of Pam Bondi as attorney general, replacing Matt Gaetz, who <a href="https://www.benzinga.com/news/24/11/42130207/trump-picks-former-florida-ag-pam-bondi-for-justice-department-after-matt-gaetz-withdraws">withdrew amid ethics concerns. </a>
Bondi, <a href="https://www.benzinga.com/news/legal/24/11/42143770/trumps-pick-for-attorney-general-is-no-matt-gaetz-when-it-comes-to-cannabis-reform">Florida's former attorney genera</a>l and a key figure in Trump's 2020 impeachment defense, is expected to refocus the Department of Justice (DOJ) under the new administration. Trump described the DOJ as "weaponized" and pledged to redirect its priorities.
Read Next:
<ul>
<li> <a href="https://www.benzinga.com/government/regulations/24/11/42144709/kennedys-war-on-food-dyes-could-be-coming-to-your-breakfast-table">Kennedy&#8217;s War On Food Dyes Could Be Coming To Your Breakfast Table</a></li>
</ul>
Image created using artificial intelligence via Midjourney.

Politics

Legal

Trump's Hush Money Sentencing Delayed As Legal Immunity Debate Escalates

<h3 class="wp-block-heading">New On The Block</h3>
<ul>
<li>Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) is looking to sell a stake in its Chinese operations. Same-store sales in China fell 14% last quarter, with the Seattle-based coffee retailer seeking partnerships to adapt to tough <a href="https://www.benzinga.com/news/asset-sales/24/11/42117962/starbucks-eyes-stake-sale-in-china-amid-fierce-competition-and-falling-sales">economic and competitive pressures</a>.</li>
</ul>
<h3 class="wp-block-heading">Bankruptcy Block</h3>
<ul>
<li>Snack producer Hearthside Food Solutions went bankrupt. The private equity-owned company looks to offload the $1.9 billion in debt accumulated under the ownership of Partners Group Holding AG and Charlesbank Capital Partners. The two firms bought Hearthside for more than $2.4 billion. Assets and liabilities hover between $1 billion and $10 billion. Last year, bankrupt private equity portfolio companies in the U.S. <a href="https://www.spglobal.com/marketintelligence/en/news-insights/latest-news-headlines/private-equity-portfolio-companies-on-track-for-most-bankruptcies-since-2020-74886821">outpaced</a> the number of <a href="https://www.benzinga.com/news/20/10/17861269/bankruptcy-update-ruby-tuesday-files-chapter-11-while-progress-slows-for-jcpenney">bankruptcies in 2020</a>. It remains to be seen whether 2024 will be worse.</li>
</ul>
<ul>
<li>Northvolt <a href="https://northvolt.com/articles/peter-carlsson-steps-aside/">filed</a> for bankruptcy with debt of $5.8 billion. Recall how the Swedish battery maker, which supplies Volkswagen AG&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/VWAGY#OTC">VWAGY</a>) and&nbsp;Bayerische Motoren Werke AG&nbsp;(OTC:<a class="ticker" href="https://www.benzinga.com/stock/BMWYY#OTC">BMWYY</a>), bargained with banks to <a href="https://www.benzinga.com/news/23/03/31506581/volkswagen-bmw-battery-supplier-northvolt-eyes-raising-5b-via-debt">raise debt last year</a>. Now, it&#8217;s hoping to restructure under U.S. Chapter 11.</li>
</ul>
See Also: <a href="https://www.benzinga.com/trading-ideas/long-ideas/24/11/42024210/benzinga-bulls-and-bears-tesla-disney-gold-and-hedge-funds-project-bitcoin-to-hit-100k-150k">Benzinga Bulls And Bears: Tesla, Disney, Gold — And Hedge Funds Project Bitcoin To Hit $100K-$150K</a>
<h3 class="wp-block-heading">Updates From The Block</h3>
<ul>
<li>Google&#8216;s $2-billion <a href="https://www.benzinga.com/news/large-cap/23/10/35474706/googles-ai-ambitions-grow-with-major-investment-in-openai-rival-anthropic">investment</a> in Anthropic is in jeopardy, according to <a href="https://www.bloomberg.com/news/articles/2024-11-21/us-justice-department-seeks-to-unwind-google-s-anthropic-deal">Bloomberg</a>. Anthropic is a Jeff Bezos-backed rival to artificial intelligence (AI) innovator OpenAI. The U.S. Department of Justice (DOJ) recommended in <a href="https://www.benzinga.com/tech/24/11/42105079/googles-unlawful-behavior-stifles-market-entry-for-rivals-doj-says-alphabet-must-sell-chrome-to-end-search-monopoly">a court filing Wednesday</a> that Alphabet Inc&#8216;s (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOG#NASDAQ">GOOG</a>) (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GOOGL#NASDAQ">GOOGL</a>) Google divest its Chrome browser to dismantle its monopoly on online search. It doesn&#8217;t end there. Google should be barred from doing any deals with companies that control where consumers search for information, regulators say. <a href="https://www.benzinga.com/tech/24/11/42123646/google-anthropic-deal-in-jeopardy-as-us-justice-department-looks-to-snap-online-search-monopoly">That includes AI products</a>.</li>
</ul>
<ul>
<li>Ricky Williams&#8216; Highsman merges with hemp brand Frozen Fields, forming Top Seed Inc. The partnership blends cannabis and hemp sectors, leveraging R&amp;D to enhance products <a href="https://www.benzinga.com/markets/cannabis/24/11/42097662/ricky-williams-highsman-merges-with-hemp-brand-frozen-fields">and control supply chains</a>.</li>
</ul>
<ul>
<li>MakeMyTrip acquires Happay from CRED. The deal is expected to enhance corporate travel and expense management solutions in India. Happay&#8217;s team will integrate with MakeMyTrip, supporting <a href="https://www.benzinga.com/general/travel/24/11/42039458/makemytrip-agrees-to-acquire-happay-bolstering-its-arsenal-for-corporate-travel-solutions">over 900 clients post-acquisition</a>.</li>
</ul>
<ul>
<li>Amcor plc (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/AMCR#NYSE">AMCR</a>) and Berry Global Group, Inc. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/BERY#NYSE">BERY</a>) agreed to merge in an all-stock transaction, with the deal valuing Berry stock <a href="https://www.benzinga.com/news/large-cap/24/11/42069248/amcor-and-berry-seal-the-deal-73-59-per-share-merger-to-forge-packaging-powerhouse">at $73.59 per share</a>.</li>
</ul>
<ul>
<li>Nippon Steel (OTC:<a class="ticker" href="https://www.benzinga.com/stock/NISTF#OTC">NISTF</a>) executives have traveled to Pennsylvania to garner support for their $15 billion acquisition bid for U.S. Steel (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/X#NYSE">X</a>). The Japanese steel giant is encountering political resistance in Washington. Takahiro Mori, vice-chair of Nippon Steel, arrived in Pittsburgh on Saturday to advocate for the acquisition. The deal faces opposition from both President Joe Biden and President-elect Donald Trump, who prefer U.S. Steel to <a href="https://www.benzinga.com/markets/24/11/42056111/nippon-steel-execs-rally-support-in-pennsylvania-amid-pushback-on-us-steel-takeover">remain under American ownership</a>.</li>
</ul>
<h3 class="wp-block-heading">Notes From The Block</h3>
Joshua Robinson, co-founder of Darwin Financial Company, announced a $55-million financing deal with INYOAG LLC. The funds will help develop a solar-powered mine in Inyo County, California where there are proven reserves of silver, lead, zinc, tungsten, and copper. Here&#8217;s our conversation with Robinson:
<h4 class="wp-block-heading">BZ: What is the deal structure between Darwin Financial and base metals miner INYOAG? </h4>
Robinson: The deal structure is a $55M project financing package split into three components: $17.5 million and $12.5 million in six-year notes tied to sulfide and oxide production respectively, plus a $20-million conditional equity commitment that only triggers if the mine hits $10 million in monthly revenue. We get 17% of gross revenues from both production tracks, structured through secure lockbox arrangements. It&#8217;s not a straight equity investment, we specifically designed it this way to provide further upside exposure.
<h4 class="wp-block-heading">Are you looking for additional investors/joint venture partners? </h4>
Yes, we&#8217;ve deliberately structured this to create multiple layers of upside potential, which is pretty unique in the mining space. We&#8217;ve created a hybrid model that offers both near-term cash flow from production and significant expansion potential. We&#8217;re already seeing interest from established mining players, but we&#8217;re particularly excited about bringing new investors into the space who understand the strategic value of critical minerals.
<h4 class="wp-block-heading">What are the downsides to depending on foreign sources of critical minerals?</h4>
China&#8217;s recent actions really highlight the urgency here. They&#8217;ve already implemented export controls on germanium and gallium, and just added antimony to that list. This isn&#8217;t theoretical anymore, it&#8217;s actively happening. We need to build regional resilience in our supply chains, particularly for these minerals that are crucial for defense and technology. The Darwin Mine gives us a unique opportunity to establish a domestic source for multiple critical minerals in a single asset, which is rare to find.
<h4 class="wp-block-heading">Will the mine be powered by solar? </h4>
The 100MW facility wouldn&#8217;t just power the mine. It would generate significant excess clean energy that we can sell back to the grid. What&#8217;s particularly interesting is that we can develop utility-scale energy storage systems using minerals we&#8217;re already producing. It creates a virtuous cycle where our mining operations directly support clean energy deployment
<h4 class="wp-block-heading">What are your 2025 goals?</h4>
For 2025, our key goals are reaching 300 tons per day on sulfide production within six months and 200 tons per day on oxide within nine months of funding. That puts us at $ 10 million in monthly revenue, which then triggers the deeper mine development program.
For last week&#8217;s Deal Dispatch, <a href="https://www.benzinga.com/ma/24/11/42025534/deal-dispatch-shell-unilever-and-more-are-on-the-sell-side-the-onion-makes-alex-jones-cry-foul">click here</a>.
Now Read: 
<ul>
<li><a href="https://www.benzinga.com/markets/equities/24/11/41699259/nvidia-rides-ai-wave-to-replace-intel-on-dow-jones-industrial-average-ending-its-25-year-run">Nvidia Rides AI Wave To Replace Intel On Dow Jones Industrial Average, Ending Its 25-Year Run</a></li>
</ul>
Image: Benzinga

Commodities

Exclusives

Interview

AMCR

BERY

BMWYY

streetTRACKS Dow Jones U.S. Large Cap Value Index Fund

GOOG

GOOGL

KRON

MEIP

NISTF

PARA

SAVE

SBUX

SHEL

TSX:SGO

ULCC

VWAGY

Deal Dispatch: Starbucks Considers China Sale, Private Equity Bankrupts Snack Company, Darwin Financial Talks Mining

Barrington Research analyst Kevin Steinke maintains ACCO Brands (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ACCO#NYSE">ACCO</a>) with a Outperform and raises the price target from $7 to $7.5.

ACCO

Barrington Research Maintains Outperform on ACCO Brands, Raises Price Target to $7.5

NODK

NI Holdings Appointed Seth Daggett As CEO, Appointed Matt Maki As Interim CFO, Both Effective Dec 1, 2024

CARA

Cara Therapeutics Receives Nasdaq Non-Compliance Notice Over Minimum Stockholders' Equity Requirement

Guidance

Quantum-Si Expects That It Will Recognize One-Time Cash Charges Related To Severance And Other Benefits Of ~$2.3M In 2024 And Another $300K In The H1 2025; Expects To Recognize Non-Cash Expense Over The Remainder Of 2024 In The Amount Of ~$200K Related To Stock Option Modifications

Quantum-Si Announces 23% Workforce Reduction As Part Of Restructuring Plan, Expects $2.6M In Severance And Related Costs Through Mid-2025

Organogenesis Holdings Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ORGO#NASDAQ">ORGO</a>), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and Surgical and Sports Medicine markets, announced plans to expand manufacturing capacity with a long-term lease for a 122,000-square foot state-of-the-art biomanufacturing facility located at 100 Technology Way in Smithfield, Rhode Island.

ORGO

Organogenesis Announces Plans To Expand Manufacturing Capacity With A Long-Term Lease A Biomanufacturing Facility Located At 100 Technology Way In Smithfield, Rhode Island

Comments

AmTrust Financial Servs

News

Latest news for AmTrust Financial Servs (OTC:AFSIB) Stock

Popular Channels

Tools & Features

Partners & Contributors

About Benzinga